OECD Expert Meeting on eHealth Indicators

empiricaBoth the European Union and the World Health Organisation (WHO) have recognised ICT-facilitated solutions as key enablers for modern, patient-centered and efficient healthcare services. To support health policies, it has become mandatory to monitor and benchmark Health ICT (eHealth) adoption and use. This is also a priority topic for EU/USA cooperation in the field of eHealth. The OECD plans to coordinate global activities, including involvement of WHO, to develop appropriate approaches and measuring tools.

empirica's director Werner B. Korte and eHealth expert Dr. Veli N. Stroetmann were invited to participate in an OECD expert meeting on May 25 on measuring the progress of global eHealth diffusion. Currently, indicators on eHealth availability and use are not uniform, and do not cover all OECD countries. The European Commission funded empirica studies on eHealth Indicators and eHealth Benchmarking compiled a comprehensive inventory of available statistical evidence on eHealth in Europe, Canada and the USA. This research also developed an indicator framework to support and guide the development of and agreement on a comprehensive set of key global indicators and procedures for data gathering on eHealth. Furthermore, detailed policy recommendations were drafted to take the work on indicators forward. Werner B. Korte and Veli Stroetmann presented the results of these studies at the OECD meeting in Paris and discussed together with other country and OECD/WHO experts and policy makers how to harmonise key global indicators, including how best to coordinate national and European surveys to comparatively measure eHealth progress.

"empirica is proud to have its long standing expertise in eHealth as well as indicator development, monitoring and benchmarking recognised at the level of the OECD and will continue to monitor and assess the eHealth landscape in Europe," concluded Werner B. Korte.

For further information, please visit:

Related news articles:

About empirica
empirica Communication and Technology Research is a private research institute founded in 1976 and based in Bonn, Germany. It specialises in communication and information technology related research and consultancy to clients in both the private and public sector. Its body of expertise ranges from long-term RTD roadmapping, policy and strategy development to pilot trials and EU-wide representative market research. The company has gained a strong profile in the practical development, pilot-testing and market validation of IST-based healthcare services. It observes and interprets market trends and evaluates the socio-economic impact of eHealth applications. In addition, it regularly conducts foresight exercises, representative surveys and compiles data bases of good practice case studies with the support of a dense network of contacts in government, industry and academia. For further information, please visit www.empirica.com.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...